Entities / Company
Moderna.
American biotechnology company
- Reports this week
- 12
- Active events
- 10
- Connections
- 309
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.Some support1 report2 developments inside
-
Johnson is investigating FDA records concerning adverse effects of Moderna vaccines.Some support1 report
-
Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.Some support1 report1 development inside
-
Moderna and BioNTech are recognized as leaders in the personalized cancer vaccine space.Some support1 report
-
Nasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.Some support1 report
-
Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.Well supported3 reports1 development inside
-
Moderna's stock gains are being driven by FDA approval and the broader growth of AI businesses, as a Nasdaq constituent.Some support1 report
-
President Stephen Hoge sold shares of Moderna stock.Some support1 report
-
Moderna and Nvidia are being discussed in the context of stock market signals.Some support2 reports
-
Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.Some support2 reports
Earlier this month
-
Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Well supported14 reports1 development inside
-
India sought vaccines from Pfizer and Moderna during COVID-19, while Piyush Goyal emphasized the need for self-reliance.Some support2 reports
-
Multiple financial firms acquired, increased, or lessened stakes in Moderna shares, while the company president also sold shares.Some support1 report
-
Uğur Şahin and Özlem Türeci plan to leave BioNTech, while Moderna and Merck advance their combined vaccine study.Some support1 report
-
MarketBeat identified Micron Technology, Intel, and Moderna as Value stocks.Some support2 reports
-
Moderna and Pfizer are developing defenses against Lyme disease, while Tarsus offers a pill for tick threats, amid surveillance discussions.Some support2 reports
-
Moderna's stock performance is tracked on Nasdaq while Leerink Partners leads a Nasdaq IPO, amid oil price volatility and AI regulation tests.Some support1 report
-
The White House announced new tariffs on Canadian imports while noting integrated supply chains and drug price headwinds affecting the healthcare sector.Some support1 report2 developments inside
-
Both Moderna and Pfizer utilize mRNA technology for gene therapy.Some support1 report
-
Moderna and Merck conducted a study on mRNA vaccine while Rob Sand campaigned for Iowa governor, proposing plans to tackle cancer.Some support1 report
-
Analysts highlighted bullish calls and raised price targets for AbbVie, Moderna, and Eli Lilly amid sector optimism.Some support1 report
-
Australian researchers announced a global cancer vaccine breakthrough on August 20, 2026, which subsequently boosted Moderna's share price.Some support1 report
-
Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.Well supported3 reports1 development inside
-
Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.Some support2 reports
-
Positive test results were reported for Moderna's flu vaccine.Some support2 reports
-
Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.Some support5 reports
-
Dolly Parton, whose roots are in rural Tennessee, donated $1 million to support COVID-19 research involving Moderna and Vanderbilt University.Well supported8 reports
-
Analysis suggests that both Moderna and Illumina stocks are currently overvalued.Some support1 report
-
Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Some support5 reports
-
Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.Well supported7 reports
-
Moderna and Merck jointly developed and presented intismeran autogene therapy at the ESMO Congress in Madrid.Well supported4 reports
One to three months ago
-
Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.Some support2 reports1 development inside
-
Moderna and Novavax partnered with Merck KGaA on an individualized neoantigen program, driven by positive Phase 2b melanoma data.Some support3 reports
-
A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.Well supported3 reports
-
Apple Inc., NetApp, and Moderna were mentioned together in a market context on September 13, 2026.Some support1 report
-
Simon Baker downgraded Moderna's stock rating from Neutral to Sell on September 3, 2026.Some support2 reports
-
MarketBeat provided average rating data for Moderna, while CLSA raised the rating and Jefferies reiterated a hold.Some support1 report
-
Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.Well supported18 reports10 developments inside
-
GlaxoSmithKline, Moderna, and Sinovac are leveraging the influenza vaccine market, with Phase 3 trials showing strong immune responses.Some support1 report2 developments inside
-
Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.Well supported5 reports
-
Moderna's higher pricing is contrasted with GSK's and Pfizer's pricing in the context of a joint procurement agreement, which was deemed vital by Hadja Lahbib.Some support1 report
-
Moderna, Tempus, and Merck partnered on the INTerpath-001 trial, which focuses on indications that are covered by Medicare.Some support2 reports
-
Moderna and Merck announced a landmark moment in vaccine testing, alongside updates regarding personnel at Moderna and Columbia University.Some support1 report
-
Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.Some support2 reports
-
Moderna and DaVita are mentioned in the context of sector strength being driven by biotech innovation.Some support1 report
-
Dolly Parton contributed funding to COVID-19 vaccine research and her legacy was celebrated by the city of New York.Some support2 reports
-
Sally Kornbluth leads MIT's academic mission, while Noubar Afeyan connects Moderna and Flagship, with Maura Healey offering support for MIT innovation.Some support1 report
-
Pfizer, BioNTech, Merck KGaA, and Moderna announced joint developments regarding Comirnaty and a new cancer treatment.Some support1 report
-
Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.Some support1 report
-
Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.Some support1 report
-
Moderna and Merck are developing an experimental melanoma vaccine with partners, while concerns about AI models are impacting Gartner's business.Some support2 reports
-
Moderna combined its vaccine with Merck's Keytruda drug.Some support3 reports
-
The event covers Halliburton's expansion into Venezuelan oil fields, Moderna's clinical trial setbacks, and general corporate supply chain trends.Some support1 report
-
Suze Orman advised against concentration risk in Moderna.Some support2 reports
-
Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.Some support2 reports
-
Stella Parton donated $1 million to support COVID-19 research into mRNA vaccines.Some support1 report
-
Dolly Parton funded research leading to vaccines and removed a Confederate word from an attraction at Dollywood.Some support1 report
-
On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.Some support1 report
-
Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.Some support1 report
-
Berkshire Hathaway and Warren Buffett commented on the Moderna and Merck partnership, criticizing market speculation while noting positive news regarding the mRNA vaccine collaboration.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Moderna
Events traced to Moderna, step by step, newest firstAround Moderna this week
News at the entities that move Moderna most-
FDA StructuralFDA conducted a nationwide product recall involving toothpaste flavored with strawberry and watermelon, featuring Barbie characters.Moves Moderna
-
Merck KGaA OperationalMerck KGaA and ABVC BioPharma are competing for investment as healthcare companies.Moves Moderna
-
Merck OperationalThe Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Moves Moderna
-
Dolly Parton TransactionalA tribute event honoring Dolly Parton featured performances by Carrie Underwood and Vince Gill, simulcast on Disney+ and shared by ABC.Moves Moderna
-
Food and Drug Administration StructuralFDA conducted a search operation in Pune on January 1, 2026.Moves Moderna
-
Centers for Disease Control and Prevention StructuralCDC estimates the spread of whooping cough in Los Angeles County.Moves Moderna
Connections
The 40 strongest of 309, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Merck KGaA Operational
Merck KGaA and Moderna maintain a strategic partnership focused on jointly developing and testing personalized mRNA cancer vaccines.
-
Merck Operational
Moderna and Merck are actively collaborating on the joint development and clinical trials of personalized mRNA cancer vaccines.
-
Dolly Parton Transactional
Dolly Parton donated $1 million to Moderna to support early COVID-19 vaccine research and development.
-
Stephen Hoge Structural
Stephen Hoge serves as President of Moderna, overseeing its commercial, R&D, and manufacturing operations.
-
FDA Structural
The FDA regulates Moderna's pharmaceutical products, granting market approval and setting guidelines that determine their commercial viability.
-
Robert Langer Structural
Robert Langer co-founded the biotech firm Moderna.
-
Noubar Afeyan Structural
Noubar Afeyan serves as a cofounder and board chair of Moderna.
-
Food and Drug Administration Structural
The FDA formally evaluates, regulates, and grants market access approvals for Moderna's products.
Show all 40 connections
-
Pfizer Operational
Moderna and Pfizer are direct, high-stakes competitors in the biopharmaceutical market, vying for market share using mRNA technology across various vaccine and gene therapy platforms.
-
Nasdaq Structural
Moderna is a constituent of the Nasdaq-100 index, and its stock performance influences the index's overall movement.
-
Lakshmi Srinivasan Structural
Lakshmi Srinivasan previously held a leadership role at Moderna.
-
Stéphane Bancel Structural
Stéphane Bancel holds the formal role of Chief Executive Officer of Moderna.
-
National Cancer Institute Structural
NCI provides funding for Moderna's mRNA trials and reports on the success of the company's research.
-
David Berman Structural
David Berman serves as the Chief Development Officer at Moderna.
-
Centers for Disease Control and Prevention Structural
CDC regulates Moderna's vaccine eligibility and operations, and Moderna receives large government contracts.
-
CNBC Operational
CNBC actively covers Moderna's corporate announcements and stock movements, while Moderna utilizes CNBC's platform for major communications.
-
European Commission Structural
The European Commission formally approved the mCOMBRIAX vaccine and subsequently entered into a procurement contract with Moderna.
-
Vanderbilt University Medical Center Structural
Vanderbilt University Medical Center provided foundational research, partnership, and funding integral to Moderna's vaccine development.
-
Flagship Pioneering Structural
Flagship Pioneering is the founding entity responsible for the creation and structure of Moderna.
-
Donald Trump Structural
Moderna's operations and funding are directly influenced by the policy decisions and regulatory actions of Donald Trump's administration.
-
Coalition for Epidemic Preparedness Innovations Operational
Moderna and CEPI are engaged in a strategic collaboration focused on developing and testing advanced vaccine candidates.
-
MSD Operational
Moderna and MSD are actively collaborating on the joint development and clinical trials of autogene therapies and mRNA vaccines.
-
Derrick Rossi Structural
Derrick Rossi is a co-founder of the biotechnology company Moderna.
-
Invesco Structural
Invesco holds Moderna as a significant investment position within its various ETFs.
-
Eli Lilly and Company Operational
The two companies are direct competitors operating within the high-risk biopharmaceutical and healthcare sectors.
-
Mike Structural
Mike holds a formal governance role on the Moderna Board of Directors and Audit Committee.
-
Michael McDonnell Structural
Michael McDonnell joined the Board of Directors of Moderna.
-
Wade Davis Structural
Wade Davis serves as the senior vice president for digital at Moderna.
-
Walgreens Operational
Walgreens serves as a key distribution point, utilizing its locations to make Moderna vaccines available to the public.
-
Novavax Operational
Novavax and Moderna are direct competitors in the vaccine market, vying for market share and influencing each other's stock performance.
-
Health Canada Structural
Health Canada acts as the required regulatory body, providing authorization necessary for Moderna to conduct clinical studies in Canada.
-
AbbVie Operational
AbbVie and Moderna are major competitors operating within the high-risk biotechnology and pharmaceutical sectors.
-
Democratic Republic of the Congo Operational
Moderna is actively conducting Ebola vaccine trials and supplying vaccines in the Democratic Republic of the Congo.
-
Department of Health & Human Services Structural
Moderna's research, funding, and operational projects are directly dependent on the grants, approvals, and funding decisions made by the Department of Health & Human Services.
-
Kennedy Operational
Kennedy criticized Moderna's mRNA technology and withdrew research grants for vaccine development.
-
Robert F. Kennedy Jr. Operational
RFK Jr.'s public challenges, lawsuits, and criticisms of mRNA technology actively influence Moderna's market perception and operational environment.
-
Gilead Sciences Operational
The companies are major players in the biotech sector and actively compete in the market.
-
North Carolina Transactional
North Carolina provided financial donations to support Moderna's vaccine development efforts.
-
Stella Parton Transactional
Stella Parton made a donation that supported Moderna's research into mRNA vaccines.
-
National Institutes of Health Operational
NIH and Moderna are engaged in a partnership to accelerate national cancer vaccine development.
History
Events by the month they beganOctober 2026
18 events- Johnson is investigating FDA records concerning adverse effects of Moderna vaccines.
- Biotech and pharmaceutical companies in Greater Boston are seeing strategic investments, talent movement, and antibody development advances.
- Moderna and BioNTech are recognized as leaders in the personalized cancer vaccine space.
- Nasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.
- Moderna and Merck reported a landmark result from their melanoma study, while SanDisk and Dell were discussed in stock market analysis.
- Moderna's stock gains are being driven by FDA approval and the broader growth of AI businesses, as a Nasdaq constituent.
- President Stephen Hoge sold shares of Moderna stock.
- Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.
- India sought vaccines from Pfizer and Moderna during COVID-19, while Piyush Goyal emphasized the need for self-reliance.
- Multiple financial firms acquired, increased, or lessened stakes in Moderna shares, while the company president also sold shares.
- Uğur Şahin and Özlem Türeci plan to leave BioNTech, while Moderna and Merck advance their combined vaccine study.
- MarketBeat identified Micron Technology, Intel, and Moderna as Value stocks.
- Moderna and Pfizer are developing defenses against Lyme disease, while Tarsus offers a pill for tick threats, amid surveillance discussions.
- Moderna's stock performance is tracked on Nasdaq while Leerink Partners leads a Nasdaq IPO, amid oil price volatility and AI regulation tests.
- Both Moderna and Pfizer utilize mRNA technology for gene therapy.
- Moderna and Merck conducted a study on mRNA vaccine while Rob Sand campaigned for Iowa governor, proposing plans to tackle cancer.
- Analysts highlighted bullish calls and raised price targets for AbbVie, Moderna, and Eli Lilly amid sector optimism.
- Australian researchers announced a global cancer vaccine breakthrough on August 20, 2026, which subsequently boosted Moderna's share price.
September 2026
17 events- Analyst downgrades and market challenges are impacting Moderna amid waning demand for COVID-19 vaccines, alongside pipeline successes.
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.
- Moderna and Merck jointly developed and presented intismeran autogene therapy at the ESMO Congress in Madrid.
- Moderna and Merck KGaA are working on personalized melanoma shots, with manufacturing challenges being discussed by Amy Walker.
- Moderna and Novavax partnered with Merck KGaA on an individualized neoantigen program, driven by positive Phase 2b melanoma data.
- Apple Inc., NetApp, and Moderna were mentioned together in a market context on September 13, 2026.
- Simon Baker downgraded Moderna's stock rating from Neutral to Sell on September 3, 2026.
- MarketBeat provided average rating data for Moderna, while CLSA raised the rating and Jefferies reiterated a hold.
- Moderna's higher pricing is contrasted with GSK's and Pfizer's pricing in the context of a joint procurement agreement, which was deemed vital by Hadja Lahbib.
- Moderna and Merck announced a landmark moment in vaccine testing, alongside updates regarding personnel at Moderna and Columbia University.
- Moderna and DaVita are mentioned in the context of sector strength being driven by biotech innovation.
- Dolly Parton contributed funding to COVID-19 vaccine research and her legacy was celebrated by the city of New York.
- Sally Kornbluth leads MIT's academic mission, while Noubar Afeyan connects Moderna and Flagship, with Maura Healey offering support for MIT innovation.
- Pfizer, BioNTech, Merck KGaA, and Moderna announced joint developments regarding Comirnaty and a new cancer treatment.
- Investor bets are shifting between the two biotech firms, Moderna and Exelixis, Inc.
- Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.
- Moderna and Merck are developing an experimental melanoma vaccine with partners, while concerns about AI models are impacting Gartner's business.
August 2026
17 events- Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.
- Dolly Parton, whose roots are in rural Tennessee, donated $1 million to support COVID-19 research involving Moderna and Vanderbilt University.
- Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.
- Insider trading filings made with the SEC regarding Moderna stock sales by President Stephen Hoge.
- A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.
- Trump administration pushes vaccine approval while FDA moves forward with Moderna vaccine, with Fauci noting incomplete protection.
- Moderna, Tempus, and Merck partnered on the INTerpath-001 trial, which focuses on indications that are covered by Medicare.
- Robert F. Kennedy Jr. collaborated on major cancer vaccine trials while criticizing mRNA technology and its potential funding.
- Moderna combined its vaccine with Merck's Keytruda drug.
- The event covers Halliburton's expansion into Venezuelan oil fields, Moderna's clinical trial setbacks, and general corporate supply chain trends.
- Suze Orman advised against concentration risk in Moderna.
- Moderna, Merck, and AbbVie are seeking new revenue streams to offset losses caused by patent expirations.
- Stella Parton donated $1 million to support COVID-19 research into mRNA vaccines.
- Dolly Parton funded research leading to vaccines and removed a Confederate word from an attraction at Dollywood.
- On August 28, 2026, the FDA approved Moderna's mNEXSPIKE vaccine and gave the green light to Novavax's Nuvaxovid vaccine. Separately, ProFound Therapeutics was formed by Flagship Pioneering.
- Developments include positive clinical results for an mRNA vaccine, a major design partnership between Google and Marvell, and macroeconomic shifts regarding currency and Bitcoin.
- Berkshire Hathaway and Warren Buffett commented on the Moderna and Merck partnership, criticizing market speculation while noting positive news regarding the mRNA vaccine collaboration.
Show 1 earlier month
June 2026
8 events- Allegations surfaced that FDA officials, including a safety data-mining expert, were involved in oversight failures regarding vaccine safety signals related to Moderna.
- Moderna and Nvidia are being discussed in the context of stock market signals.
- The White House announced new tariffs on Canadian imports while noting integrated supply chains and drug price headwinds affecting the healthcare sector.
- Major pharmaceutical companies face industry-wide pressure from patent cliffs and the need to streamline operations.
- Positive test results were reported for Moderna's flu vaccine.
- Trump's policies, including tariffs and onshoring, are being discussed in the context of their potential benefits for AI stocks, with specific attention paid to Moderna's performance and guidance.
- Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.
- GlaxoSmithKline, Moderna, and Sinovac are leveraging the influenza vaccine market, with Phase 3 trials showing strong immune responses.